Ask A Lawyer
Talk to a Fosamax Lawyer for a free case review.
Merck & Co. is the manufacturer of Fosamax and responsible for Fosamax injury.
Over 36 million women use Fosamax to slow down, prevent, and treat osteoporosis. Merck's multi-million dollar ad campaign has generated $3.2 billion dollars from last year's sale of Fosamax. Once used to only treat osteoporosis, doctors are now prescribing Fosamax to younger women to prevent osteoporosis. Our pill popping society is just confidently eating it up.
The complete ravages of Fosamax injury are unknown. Bisphosphonates remain in the body indefinitely so long range effects are still unknown. Reports are starting to surface about patients who have had dental or oral surgeries and then deterioration or death of jaw bones. All patients had one thing in common — they were taking Fosamax or bisphosphonate medications for osteoporosis.
Merck has been slow to warn healthcare professionals and place an adequate warning label on Fosamax regarding the Fosamax injury of jawbone death also known as ONJ. Merck doesn't want this most debilitating and painful Fosamax injury to interfere with the billion dollar sales of its second best-selling medication. Merck is currently facing thousands of lawsuits by not properly labeling Vioxx.
Merck is responsible for Fosamax injury. Contact a Fosamax lawyer for a free consultation about your possible Fosamax class action suit.
Proctor and Gamble is the manufacturer of Actonel and responsible for Actonel injury. Actonel (generic name risedronate) is in a class of drugs called bisphosphonates which is used for the treatment of Paget's disease (a disease in which the formation of bone is abnormal) and for osteoporosis.
Actonel has been linked to ONJ (osteonecrosis) or dead or rotting jawbone. Warning labels have not been as specific as they could be to warn doctors and patients about the dangers of dead jawbone and their link to oral surgeries.
Proctor and Gamble is responsible for Actonel injury. Contact an Actonel lawyer for a free consultation about your possible Actonel class action lawsuit.
Novartis manufactured Aredia (generic name pamidronate disodium) a potent intravenous bisphosphonate and is responsible for Aredia injury. Aredia injection was used in conjunction with t-cell therapy for the treatment of breast cancer and bone marrow cancer, as well as hypercalcemia of malignancy (HCM) and Paget's disease.
In 2002, the FDA received nine spontaneous reports of osteonecrosis of the jaw (ONJ) in patients with malignancy whose treatment regiments included intravenous bisphosponates like Aredia and Zometa. Aredia is no longer on the market but its long-term effects remain.
Novartis manufactures Zometa (generic name zoledronic acid) a potent intravenous bisphosphonate. Zoledronic acid injection is indicated for the treatment of HCM (hypercalcemia of malignancy) and for patients with bone cancer.
The FDA received reports of osteonecrosis of the jaw (ONJ) in cancer patients who required dental surgery. In 2003, Novartis updated the label to include the warning about dental surgery. Even after stopping the use of Zometa, bisphosphonates remain in the body and there is no way of knowing how it will affect dental surgeries.
Novartis Pharma is responsible for Zometa injury. Contact an expert Zometa law firm for a free consultation about your Zometa lawsuit.